PropThink: Dendreon Q3 Earnings Preview: Can the Company Overcome the Odds?

[ACN Newswire] – By Ivan DeryuginOne of the most controversial companies in the biotechnology sector today is Dendreon (NASDAQ:DNDN). To some, the company represents the worst of Wall Street, an overhyped company with … more

View todays social media effects on DNDN

View the latest stocks trending across Twitter. Click to view dashboard